Pharmacokinetic/Laboratory Studies

IRB 15-2767: The Compartmental Biology of HIV in the Male Genital Tract

  • Question: To better understand the pharmacoloty of antiretroviral therapy (ART) in the male genital tract, to study virus shed in spite of treatment, and the conditions (factors) in semen that appear to permit HIV detection. We hope these results will determine the basis for "residual shedding"
  • Population: Male volunteers between ages 18-60, inclusive, on tenofovir/emtricitabine for treatment OR prevention
  • Medication: NONE
  • Duration: Screening within 42 days of enrollment; One 48-hour inpatient visit where 6 paired blood and semen samples will be collected
  • Call: Heather Prince, PA-C 919-962-5344

Status: On-going / Recruiting

 

IRB 16-0398: Measuring Adherence in Hair

  • Question: We will investigate the influence of race, hair color and hair treatment on ARV response with infra-red (IR)-matrix-assisted laser desorption electrospray ionization (MALDESI) imaging, and evaluate sample pre-treatment or extraction to obtain a standardized response from MSI of hair strands.
  • Population: Male of female volunteers adherent to regimens including maraviroc, dolutegravir, or tenofovir/emtricitabine
  • Medication: NONE
  • Duration: One hair sample collection
  • Call: Heather Prince, PA-C 919-962-5344

Status: On-going / Recruiting